FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

Smallpox/Mpox Vaccine OKd Despite CBER Turmoil

FDA approves Bavarian Nordics freeze-dried formulation of Jynneos smallpox and mpox vaccine despite concerns over CBER director Peter Marks departure ...

latest-news-card-1
Human Drugs

Vanda Files NDA for Antipsychotic Drug

Vanda Pharmaceuticals files an NDA for Bysanti (milsaperidone) for treating acute Bipolar I disorder and schizophrenia.

latest-news-card-1
Human Drugs

Imfinzi Wins Approval for Bladder Cancer

FDA approves AstraZenecas Imfinzi (durvalumab) for treating adults with muscle invasive bladder cancer.

FDA General

Trump Order Stifles Union Representation at FDA

President Trump signs an executive order to remove organized union representation from the majority of government agencies, including FDA, to make it ...

latest-news-card-1
Human Drugs

Merck Touts Data in Pulmonary Arterial Hypertension

Merck reports data from its Phase 3 ZENITH trial that showed Winrevair (sotatercept-csrk) significantly reduces the risk of major morbidity and mortal...

latest-news-card-1
Medical Devices

FDA Clears TrainHealths Neuromuscular Stimulator

FDA clears a TrainHealth 510(k) for its TrainFES neuromuscular stimulator and its use in treating people with sequelae of stroke and spinal cord injur...

latest-news-card-1
Medical Devices

FDA Loses on Regulating Lab-Developed Tests

Eastern Texas federal judge Sean Jordan rules against FDA in a case challenging the agencys final rule regulating laboratory-developed tests.

latest-news-card-1
Medical Devices

FDA Green Lights At-Home Sexual Disease Test

FDA grants Visby Medical a de novo marketing clearance for its Womens Sexual Health Test, a non-prescription at-home diagnostic test for chlamydia, go...

latest-news-card-1
Human Drugs

Meeting on Opioid Postmarketing Studies Set for 5/5

FDA reschedules for 5/4 a previously planned joint advisory committee meeting on studies that looked at the use of opioid analgesics for management of...

latest-news-card-1
Human Drugs

Novartis Wins Expanded Pluvicto Use in Prostate Cancer

FDA approves a Novartis supplemental NDA to expand the indication for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to include adults with prostate...